FDA policy on women in drug trials.
作者信息
Caschetta M B, Chavkin W, McGovern T
出版信息
N Engl J Med. 1993 Dec 9;329(24):1815-6. doi: 10.1056/NEJM199312093292414.
PMID:8232495
Abstract
摘要
相似文献
1
FDA policy on women in drug trials.
N Engl J Med. 1993 Dec 9;329(24):1815-6. doi: 10.1056/NEJM199312093292414.
2
New FDA policy encourages inclusion of women in clinical trials.
Clin Pharm. 1993 Oct;12(10):712-3.
3
Women in clinical trials of new drugs. A change in Food and Drug Administration policy. The Working Group on Women in Clinical Trials.
N Engl J Med. 1993 Jul 22;329(4):292-6. doi: 10.1056/NEJM199307223290429.
4
FDA wants to invite women into drug trials earlier.
Nature. 1992 Nov 26;360(6402):289. doi: 10.1038/360289a0.
5
FDA clarifies rules for getting experimental drugs.
J Natl Cancer Inst. 2007 Apr 18;99(8):584-5, 589. doi: 10.1093/jnci/djk170.
6
FDA scrutiny and pediatric clinical investigations.
Cost Qual. 2001 Jun:33-6.
7
FDA insists on more women in drug trials.
BMJ. 1997 Oct 4;315(7112):833.
8
New clinical trials policy at FDA.
Nat Biotechnol. 2006 Sep;24(9):1043. doi: 10.1038/nbt0906-1043. Epub 2006 Sep 1.
9
10
Does exclusion or inclusion better protect women?
J Gend Specif Med. 1998 Oct-Nov;1(2):18-22.
Zotero 插件